Ss. Lakka et al., In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2, CLIN EXP M, 18(3), 2000, pp. 239-244
Human tissue factor pathway inhibitor-2 (TFPI-2) is a Kunitz-type serine pr
otease inhibitor that inhibits plasmin, trypsin, chymotrypsin, cathepsin G
and plasma kallikrein but not urokinase (uPA) or tissue-type plasminogen ac
tivator and thrombin. Earlier studies from our and other laboratories have
shown that the production of TFPI-2 is downregulated during the progression
of various cancers. To investigate the role of TFPI-2 in the invasion and
metastasis of lung tumors, the human lung cancer cell line A549, which prod
uces high levels of TFPI-2, was stably transfected with a vector capable of
expressing an antisense transcript complementary to the full-length TFPI-2
mRNA. Northern blot analysis was used to quantify the TFPI-2 mRNA transcri
pt, and western blot analysis was used to measure TFPI-2 protein levels in
parental cells and stably transfected (vector and antisense) clones. The le
vels of TFPI-2 mRNA and protein were significantly less in antisense clones
than in the parental and vector controls. The invasive potential of the pa
rental cells and stably transfected vector clones in vitro, as measured by
the Matrigel invasion assay, was also markedly less than that of antisense
clones. Further characterization of these clones showed that more cells mig
rated from antisense clones than from parental and vector clones. These dat
a suggest that TFPI-2 is critical for the invasion and metastasis of lung c
ancer and that the downregulation of TFPI-2 production may be a feasible ap
proach to increase invasiveness and metastasis.